Wednesday, June 18, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

Update: 1

From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 17 Jun 2008 07:21:15 -0500 (CDT)
Subject: FDA News Digest

FDA News Digest

June 17, 2008

_____________________________________

IN THIS WEEK'S ISSUE

» News

-- Administration Proposes More Funding to Improve Food, Medical Product Safety

-- FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs

» Congressional Testimony

» Safety Alerts/Recalls

» Upcoming Public Meetings

» Consumer Health Information

__________________________________________

NEWS

Administration Proposes More Funding to Improve Food, Medical Product Safety

The administration is amending its budget request for fiscal year 2009 to include an additional $275 million for FDA. The budget amendment proposes increases for core FDA programs in food supply protection; drug, device, and biologics safety; and science and workforce modernizing.

http://www.hhs.gov/news/press/2008pres/06/20080609a.html

FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs

FDA is requiring manufacturers of an older class of drugs known as "conventional" antipsychotics to make changes in labeling to warn that clinical studies indicate that those drugs are associated with an increased risk of death when used in elderly patients treated for dementia.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01851.html

To view an archive of recent FDA news releases, go to

To access the RSS feed of FDA news releases, go to

http://www.fda.gov/bbs/topics/news/rssPress.xml.

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

_____________________________________________

CONGRESSIONAL TESTIMONY

June 12 -- FDA Associate Commissioner for Foods David Acheson, M.D., appeared before the House Subcommittee on Oversight and Investigations.

Subject: ongoing activities to implement the Food Protection Plan

http://www.fda.gov/ola/2008/fpp061208.html

June 10 -- FDA Associate Commissioner for Science Norris Alderson, Ph.D., appeared before the House Subcommittee on Commerce, Trade and Consumer Protection.

Subject: safety of bisphenol A (BPA)

http://www.fda.gov/ola/2008/BPA061008.html

To view an archive of past testimony by FDA officials, go to

http://www.fda.gov/ola/listing.html

__________________________________________________________

SAFETY ALERTS/RECALLS

Safety Alert:

FDA is continuing to warn consumers nationwide that a salmonellosis outbreak has been linked to certain raw red plum, red Roma, and red round tomatoes, and products containing these raw, red tomatoes.

http://www.fda.gov/oc/opacom/hottopics/tomatoes.html

For a list of recalls, market withdrawals, and safety alerts involving FDA-regulated

products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.

To access the RSS feed of FDA recalls information, go to

http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

____________________________________________________________________

UPCOMING PUBLIC MEETINGS

For a complete list of upcoming meetings, seminars, and other public events sponsored

or co-sponsored by FDA, go to http://www.fda.gov/opacom/hpmeetings.html.

CONSUMER HEALTH INFORMATION

Consumer updates in the spotlight this week are:

Your Guide to Reporting Problems to FDA

http://www.fda.gov/consumer/updates/reporting_guide061008.html

FDA 101: How to Use the Consumer Complaint System and MedWatch

http://www.fda.gov/consumer/updates/reporting061008.html

To receive all consumer updates by e-mail, go to http://www.fda.gov/consumer/consumerenews.html.

For the latest in consumer health news from FDA, visit http://www.fda.gov/consumer/default.htm.

Thanks for subscribing to FDA News Digest.

Our next issue will be sent June 23.


Update: 2
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 17 Jun 2008 10:05:46 -0500 (CDT)
Subject: FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'

FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Tue, 17 Jun 2008 09:30:00 -0500

Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration today. The FDA also warns North American consumers against using or purchasing the products, which include tablets, teas, tonics, black salves, and creams, and are sold under various names on the Internet.


Update: 3
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 17 Jun 2008 10:36:28 -0500 (CDT)
Subject: U.S. Food & Drug Administration (FDA) CBER's Guidances Update

You are subscribed to CBER's Guidances for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.

Guidance for Industry: Indexing Structured Product Labeling (Revision 1) - 6/17/2008


Update: 4
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 17 Jun 2008 11:04:53 -0500 (CDT)
Subject: Beware of Online Cancer Fraud

Beware of Online Cancer Fraud
Tue, 17 Jun 2008 10:38:00 -0500

FDA and the Federal Trade Commission have launched a program targeting online health fraud that takes advantage of people with cancer. Protect yourself with this advice.


Update: 5
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 17 Jun 2008 12:49:20 -0500 (CDT)
Subject: Recent Device Approvals: Biotronik Left Ventricular Pacing Leads

You are subscribed to Recent Device Approvals updates for U.S. Food & Drug Administration (FDA). Information about Biotronik's Stratos LV and Stratos LV T CRT Ps and Corox OTW BP and Corox OTW S BP Left Ventricular Pacing Leads has recently been posted to the FDA website, and is now available.


Update: 6
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 17 Jun 2008 19:03:58 -0500 (CDT)
Subject: Tipu's Tiger Chai, Inc Recalls Tipus Tiger Chai Concentrate Because of a Possible Health Risk (June 17)

Tipu's Tiger Chai, Inc Recalls Tipus Tiger Chai Concentrate Because of a Possible Health Risk (June 17)
Tue, 17 Jun 2008 18:48:00 -0500

Tipu's Tiger Chai Inc, of Missoula, Montana is voluntarily recalling its Tipu's Tiger Chai Concentrate because it has the potential to be contaminated with Clostridium botulinum, a bacterium which can cause life-threatening illness or death. Consumers are warned not to use the product even if it does not look or smell spoiled.


This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420